amlodipine and benazepril hydrochloride (57237-143)

Drug Facts

Product Profile

Brand Name amlodipine and benazepril hydrochloride

Generic Name amlodipine and benazepril hydrochloride

Labeler rising pharma holdings, inc.

Dosage Form CAPSULE

Routes

ORAL

Active Ingredients

amlodipine besylate 5 mg/1, benazepril hydrochloride 10 mg/1

Manufacturer

Rising Pharma Holdings, Inc.

Identifiers & Regulatory

Product NDC 57237-143

Product ID 57237-143_a4aff76f-e9a9-4300-b42c-616d8ca55d5d

Product Type HUMAN PRESCRIPTION DRUG

Marketing Category ANDA

Application Number ANDA202239

Listing Expiration 2026-12-31

Marketing Start 2012-09-05

Pharmacologic Class

Classes

angiotensin converting enzyme inhibitor [epc] angiotensin-converting enzyme inhibitors [moa] calcium channel antagonists [moa] calcium channel blocker [epc] cytochrome p450 3a inhibitors [moa] decreased blood pressure [pe] dihydropyridine calcium channel blocker [epc] dihydropyridines [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 57237143

Hyphenated Format 57237-143

Supplemental Identifiers

RxCUI

898342 898346 898350 898353 898356 898359

UPC

0357237143018 0357237142011 0357237146019 0357237147016 0357237145012 0357237144015

UNII

864V2Q084H N1SN99T69T

Packaging Origin

Original Packager

true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name amlodipine and benazepril hydrochloride (source: ndc)

Generic Name amlodipine and benazepril hydrochloride (source: ndc)

Application Number ANDA202239 (source: ndc)

Routes

ORAL

source: ndc

Resolved Composition

Strengths

5 mg/1
10 mg/1

source: ndc

Packaging

100 CAPSULE in 1 BOTTLE (57237-143-01)
500 CAPSULE in 1 BOTTLE (57237-143-05)

source: ndc

Packages (2)

57237-143-01 100 CAPSULE in 1 BOTTLE (57237-143-01) 57237-143-05 500 CAPSULE in 1 BOTTLE (57237-143-05)

Ingredients (2)

amlodipine besylate (5 mg/1) benazepril hydrochloride (10 mg/1)

Linked Drug Pages (1)

Amlodipine and Benazepril Hydrochloride ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload

{"route": ["ORAL"], "spl_id": "a4aff76f-e9a9-4300-b42c-616d8ca55d5d", "openfda": {"upc": ["0357237143018", "0357237142011", "0357237146019", "0357237147016", "0357237145012", "0357237144015"], "unii": ["864V2Q084H", "N1SN99T69T"], "rxcui": ["898342", "898346", "898350", "898353", "898356", "898359"], "spl_set_id": ["03b175fc-d430-490d-b7ac-9f7a2cb1dd8b"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (57237-143-01)", "package_ndc": "57237-143-01", "marketing_start_date": "20120905"}, {"sample": false, "description": "500 CAPSULE in 1 BOTTLE (57237-143-05)", "package_ndc": "57237-143-05", "marketing_start_date": "20120905"}], "brand_name": "Amlodipine and Benazepril Hydrochloride", "product_id": "57237-143_a4aff76f-e9a9-4300-b42c-616d8ca55d5d", "dosage_form": "CAPSULE", "pharm_class": ["Angiotensin Converting Enzyme Inhibitor [EPC]", "Angiotensin-converting Enzyme Inhibitors [MoA]", "Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Decreased Blood Pressure [PE]", "Dihydropyridine Calcium Channel Blocker [EPC]", "Dihydropyridines [CS]"], "product_ndc": "57237-143", "generic_name": "Amlodipine and Benazepril Hydrochloride", "labeler_name": "Rising Pharma Holdings, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Amlodipine and Benazepril Hydrochloride", "active_ingredients": [{"name": "AMLODIPINE BESYLATE", "strength": "5 mg/1"}, {"name": "BENAZEPRIL HYDROCHLORIDE", "strength": "10 mg/1"}], "application_number": "ANDA202239", "marketing_category": "ANDA", "marketing_start_date": "20120905", "listing_expiration_date": "20261231"}